Accreditation/Credit Designation

Physicians’ Education Resource®, LLC, is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

Physicians’ Education Resource®, LLC, designates this enduring material for a maximum of 1.0 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Physicians’ Education Resource®, LLC, is approved by the California Board of Registered Nursing, Provider #16669, for 1.0 Contact Hours.

Acknowledgment of Commercial Support

This activity is supported by an educational grant from Sanofi Genzyme Corporation.

Community Practice Connections™: Optimizing Outcomes Through Stem Cell Mobilization: Equipping Transplant Centers to Make the Most of ASCT

Release Date: December 19, 2019
Expiration Date: December 19, 2020
Media: Internet - based

Activity Overview

Successful autologous stem cell transplantation (ASCT) plays a critical role in treatment of non-Hodgkin lymphoma and multiple myeloma, and ASCT outcomes are dependent on mobilization of peripheral blood stem cells. This activity will serve to update practitioners on emerging evidence-based strategies to optimize outcomes from stem cell mobilization, including how to incorporate new agents and techniques for monitoring mobilization, and how to identify patients likely to achieve the best outcomes with ASCT. Throughout the program, expert interviews will serve to reinforce and contextualize emerging data to help you integrate best practices in ASCT for the care of your patients.

Benefits of Participating

  • Gain an understanding of the latest emerging data regarding agents that are available to increase the efficacy of stem cell mobilization
  • Hear expert perspectives on how best to incorporate new data into patient management strategies during ASCT
  • Challenge your understanding of evolving strategies to optimize ASCT outcomes in the context of case-based scenarios

Acknowledgement of Commercial Support

This activity is supported by an educational grant from Sanofi Genzyme Corporation.

Instructions for This Activity and Receiving Credit

  • You will need to log in to participate in the activity.
  • Each presentation may contain an interactive question(s). You may move forward through the presentation; however, you may not go back to change answers or review audio/content until you finish the presentation.
  • At the end of the activity, “Educational Content/Videos” will be available for your reference.
  • In order to receive a CME/CE Certificate, you must complete the activity.
  • Complete the Posttest and pass with a score of 70% or higher, complete the Evaluation, and then click on “Request for Credit.” You may immediately download a CME/CE Certificate upon completion of these steps.

Target Audience

This educational program is primarily directed toward community oncologists, hematologists, and transplant specialists who treat patients with hematologic malignancies. Additionally, fellows, nurses, nurse practitioners, physician assistants, and other healthcare professionals involved in the treatment of hematologic malignancies are also invited to participate in the activity.

Learning Objectives

Upon successful completion of this educational activity, you should be better prepared to:

  • Describe current strategies for optimal stem cell transplantation in patients with multiple myeloma and non-Hodgkin lymphoma prior to autologous stem cell transplantation therapy
  • Identify factors that affect the efficacy of stem cell mobilization
  • Implement individualized treatment strategies to effectively mobilize stem cells for successful transplantation
  • Implement adverse-effect management strategies to optimize outcomes in patients undergoing stem cell mobilization and transplant

Faculty, Staff, and Planners’ Disclosures


Paul Shaughnessy
Paul Shaughnessy, MD
Medical Director
Texas Transplant Institute
San Antonio, TX

Disclosures: Speakers Bureau: Kite Pharma, Millennium Pharmaceuticals, Sanofi, Takeda.

Shaji Kumar
Shaji Kumar, MD
Hematologist/Internist, Consultant
Division of Hematology
Department of Internal Medicine
Professor of Medicine
Mayo Clinic Cancer Center
Rochester, MN

Disclosures: Speakers Bureau: Kite Pharma, Millennium Pharmaceuticals, Sanofi, Takeda.

The staff of Physicians' Education Resource®, LLC (PER®) have no relevant financial relationships with commercial interests to disclose.

Disclosure Policy and Resolution of Conflicts of Interest (COI)

As a sponsor accredited by the ACCME, it is the policy of PER® to ensure fair balance, independence, objectivity, and scientific rigor in all of its CME/CE activities. In compliance with ACCME guidelines, PER® requires everyone who is in a position to control the content of a CME/CE activity to disclose all relevant financial relationships with commercial interests. The ACCME defines “relevant financial relationships” as financial relationships in any amount occurring within the past 12 months that creates a COI.

Additionally, PER® is required by ACCME to resolve all COI. PER® has identified and resolved all COI prior to the start of this activity by using a multistep process.

Off-Label Disclosure and Disclaimer

This CME/CE activity may or may not discuss investigational, unapproved, or off-label use of drugs. Participants are advised to consult prescribing information for any products discussed. The information provided in this CME/CE activity is for continuing medical and nursing education purposes only and is not meant to substitute for the independent clinical judgment of a physician and nurse relative to diagnostic or treatment options for a specific patient’s medical condition.

The opinions expressed in the content are solely those of the individual faculty members and do not reflect those of PER® or the company that provided commercial support.

Login or Register to Start Activity

Please use the form below to Register or Log In to begin Activity.

*Required Fields
Calendar of Events
Filter By